Indications

Prescribing Information

Next Page Icon

Medication Guide

Next Page Icon
Woman looking at patient resources such as the OPDIVO® with You support program, side effect tracker and more.
Woman looking at patient resources such as the OPDIVO® with You support program, side effect tracker and more.

Helpful resources
for patients

You don’t have to do it all alone. Along with your support network of family and caregivers, the OPDIVO with You support program and additional resources below are available to help you along your treatment journey.

Actor portrayal.

Wallet card icon

Wallet card

Create a contact card to keep your treatment and oncologist information close by. You can either print out this card or digitally save it to your device.

Side effect tracker

Download the side effect tracker to track symptoms and other important information so that you can proactively manage potential side effects with your doctor.

Questions to ask your doctor

If you’re considering either OPDIVO or OPDIVO + YERVOY as a treatment option, these questions can help you start a conversation with your doctor at your next appointment.

If you and your doctor are considering OPDIVO or OPDIVO + YERVOY, be sure to discuss your existing health problems, prescription medications, and non-prescription medicines, including vitamins and herbal supplements. Your doctor is always the best source of information when it comes to your health.

What is immunotherapy?

How is OPDIVO or OPDIVO + YERVOY different from traditional chemotherapy?

How does OPDIVO or OPDIVO + YERVOY work?

What are the potential benefits of an OPDIVO treatment?

How are OPDIVO treatments given?

How often will I need OPDIVO treatments, and how long will they take?

What are the potential side effects that I may experience?

Will this treatment affect my daily life in any way?

How will I know if the treatment is working?

Advocacy and support organizations*

Below are additional organizations with resources that you may find helpful, along with specific organizations for people living with lung cancer, kidney cancer, gastroesophageal cancer, and melanoma.

The Cancer Support Community is an international nonprofit dedicated to providing support, education, and hope to people affected by cancer and their loved ones.

Logo for CancerCare®.

The mission of CancerCare is to provide free, professional support services to anyone affected by cancer.

Logo for the American Cancer Society®.

The American Cancer Society’s mission is to save lives, celebrate lives, and lead the fight for a world without cancer.

Logo for Crossroads4Hope®.

Our network embraces all people touched by cancer—the diagnosed and their loved ones—to become empowered to take control of their health and care, through programs of support, resources, education, well-being, and hope.

The Latino Cancer Institute is a nonprofit network dedicated to the promotion of education, services, research, and policy that impact Latinos nationwide around issues of cancer.

The National LGBT Cancer Network works to improve the lives of LGBT cancer survivors and those at risk by educating the community, training providers, and advocating for LGBT survivors.

Cancer Research Institute (CRI) is dedicated to pursuing research in and advancing awareness of immunotherapy for cancer.

Stand Up To Cancer works relentlessly to offer the newest, most effective, and most promising cancer treatments to patients quickly by bringing together the best minds to collaborate, innovate, and share cancer research.

* Bristol Myers Squibb does not endorse these organizations. The information/links provided by Bristol Myers Squibb are meant for informational purposes only and are not meant to replace a physician’s medical advice.
Nurse monitoring a gentleman's infusion of OPDIVO® (nivolumab) immunotherapy treatment.

Getting an infusion

See your recommended treatment plan and what to expect from an infusion

OPDIVO® (nivolumab) side effects.

Side effects

View side effects of treatment and learn how to manage them

Clinical trial results for OPDIVO® (nivolumab) and OPDIVO-based combinations.

Clinical trial results

Explore findings from clinical trials with OPDIVO and OPDIVO-based combinations



1506-US-2400111   03/24